La Jolla urges shareholders to approve Adamis merger
This article was originally published in Scrip
Executive Summary
La Jolla Pharmaceuticals has updated its shareholders on its proposed merger with Adamis Pharmaceuticals in an attempt to secure approval at a special meeting on February 26th.